Lycera is a biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer.

Pharmaceutical

Lycera

Lycera's headquarters in Ann Arbor, MI, United States

Alex G. Howarth

H. Jeffrey Wilkins

Laura L. Carter

Steve Gillis

Nicholas J. Simon

Pablo Cagnoni

Doug Fisher

Mary Lincoln Campbell

Kristina Burow

Robert Kamen

The Research and Development Team at Lycera focuses on advancing innovative small molecule therapies targeting autoimmune diseases and cancer. Comprising experts in biology, chemistry, and preclinical development, the team collaborates to discover, design, and optimize drug candidates, rigorously evaluating their efficacy and safety in preclinical models to drive promising therapies toward clinical application.

Research and Development Team

The Leadership Team at Lycera is responsible for shaping the strategic direction and vision of the company. Comprising experts in medical, biological, and chemical fields, the team drives the development of innovative small molecule therapies for autoimmune diseases and cancer, overseeing research initiatives, regulatory strategies, and collaboration efforts to ensure the successful translation of scientific discovery into viable treatments.

Lycera

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Offices

Similar companies